VIVEbiotech
Stand: 56
- Advanced Therapies Europe
- Bronze Sponsor
- CDMO/CMO services
- Gene Therapy
- Cell Based-IO
- Contract Development and Manufacturing Organisation/Contract Manufacturing Organisation
)
){kind=logo}
VIVEbiotech is a GMP-compliant CDMO exclusively specialized in lentiviral vector manufacturing for gene-modified cell and gene therapy applications — the only company in Europe with this dedicated focus.
With more than 10 years' experience, over 200 GMP batches produced and more than 70 completed projects for 60+ international clients, VIVEbiotech delivers high-quality, cost-effective lentiviral vectors meeting FDA and EMA standards.
Recently launched its EvoLVcell platform (stable producer cell lines) to enhance reproducibility and cost-efficiency.
Address
Tandem BuildingMiramon Pasealekua 170
1st floor
Donostia - San Sebastian
Spain
20014
Spain
Website
https://vivebiotech.com/en/Contact Exhibitor
-
)
VIVEbiotech is the only GMP CDMO in Europe exclusively focused on lentiviral vector manufacturing. With 10+ years of experience and over 50 GMP batches—half in the last 3 years—we offer regulatory com ...
-
VIVEbiotech wins “CMO/CDMO of the Year” at the Advanced Therapies Awards, recognizing our excellence and innovation in gene therapy manufacturing. A proud start to 2025! -
)
VIVEbiotech celebrates 10 years of innovation, growth, and global impact in lentiviral vector manufacturing, marking a decade of excellence in gene therapy support. -
)
VIVEbiotech secures growth investment from Ampersand Capital to expand lentiviral vector manufacturing and support global gene and cell therapy development.